Jeffrey M Leiden Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Jeffrey M Leiden is Executive Chairman of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 24,027 shares of VRTX, which is worth approximately $10.4 Million. The most recent transaction as insider was on May 05, 2023, when has been sold 879 shares (Common Stock) at a price of $349.84 per share, resulting in proceeds of $307,509. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24K

0% 3M change

140.41% 12M change

Total Value Held $10.4 Million

JEFFREY M LEIDEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 05 2023	SELL Open market or private sale	$307,509 $349.84 p/Share	879 Reduced 2.35%	36,512 Common Stock
May 03 2023	SELL Open market or private sale	$1,579,828 $350.45 p/Share	4,508 Reduced 10.76%	37,391 Common Stock
May 02 2023	SELL Open market or private sale	$2,264,272 $351.05 p/Share	6,450 Reduced 13.34%	41,899 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$3,969,617 $289.12 p/Share	13,730 Reduced 22.12%	48,349 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$3,979,981 $298.26 p/Share	13,344 Reduced 17.69%	62,079 Common Stock
Feb 02 2023	SELL Payment of exercise price or tax liability	$1,137,195 $317.83 p/Share	3,578 Reduced 4.53%	75,423 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	76,578 Added 49.22%	79,001 Common Stock

Jul 25 2022	SELL Open market or private sale	$37,165,712 $281.39 p/Share	132,079 Reduced 98.2%	2,423 Common Stock
Jul 25 2022	BUY Exercise of conversion of derivative security	$5,494,139 $91.05 p/Share	60,342 Added 30.97%	134,502 Common Stock
Apr 13 2022	SELL Open market or private sale	$4,563,653 $289.04 p/Share	15,789 Reduced 17.55%	74,160 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$2,766,448 $227.86 p/Share	12,141 Reduced 11.89%	89,949 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$1,914,952 $232.51 p/Share	8,236 Reduced 7.47%	102,090 Common Stock
Feb 02 2022	SELL Payment of exercise price or tax liability	$1,529,753 $243.63 p/Share	6,279 Reduced 5.38%	110,326 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	66,817 Added 36.43%	116,605 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$2,958,148 $211.75 p/Share	13,970 Reduced 21.95%	49,676 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$2,988,389 $214.16 p/Share	13,954 Reduced 17.98%	63,646 Common Stock
Feb 03 2021	SELL Payment of exercise price or tax liability	$1,849,043 $215.03 p/Share	8,599 Reduced 9.98%	77,600 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	83,888 Added 49.32%	86,199 Common Stock

JML

Jeffrey M Leiden

Executive Chairman

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account